Neuralink opens enrollment for its first human BCI implants

Elon Musk's Neuralink company, purveyors of the experimental N1 brain-computer interface (BCI), announced on Tuesday that it has finally opened enrollment for its first in-human study, dubbed Precise Robotically Implanted Brain-Computer Interface (PRIME, not PRIBCI). The announcement comes nearly a year after the company's most recent "show and tell" event, four months beyond the timeframe Musk had declared the trials would start, and nearly a month after rival Synchron had already beaten them t...